A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence

Neuroscience

Volumn 254, Issue , 2013, Pages 452-475

  Shen, H ^a   Mohammad, A ^a   Ramroop, J ^a   Smith, S S ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

Allopregnanolone; CA1 hippocampus; Flumazenil; Methamphetamine; Pregnanolone; Stress

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ELTANOLONE; FLUMAZENIL; METHAMPHETAMINE; NEUROSTEROID; GABRA4 PROTEIN, RAT; PREGNANE-20-ONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CELL ADHESION; GABAERGIC SYSTEM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HYPERPOLARIZATION; ISOMER; LONG TERM EXPOSURE; MALE; METHAMPHETAMINE DEPENDENCE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STARTLE REFLEX; STEROID RELEASE; ANALOGS AND DERIVATIVES; ANIMAL; ANXIETY; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED; DRUG ABUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; LONG EVANS RAT; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; RAT; SENSORY GATING; WITHDRAWAL SYNDROME;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANXIETY; GENE EXPRESSION REGULATION; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; PREGNANOLONE; RATS; RATS, LONG-EVANS; RECEPTORS, GABA-A; SENSORY GATING; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84887613560     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.033     Document Type: Article

References (128)

1. Agis-Balboa R.C., Pinna G., Zhubi A., Maloku E., Veldic M., Costa E., Guidotti A. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci 2006, 103:14602-14607.
2. Anker J.J., Carroll M.E. Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug Alcohol Depend 2010, 107:264-267.
3. Anker J.J., Holtz N.A., Zlebnik N., Carroll M.E. Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats. Psychopharmacology (Berl) 2009, 203:63-72.
4. Back S.E., Hartwell K., Desantis S.M., Saladin M., McRae-Clark A.L., Price K.L., Moran-Santa Maria M.M., Baker N.L., Spratt E., Kreek M.J., Brady K.T. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend 2010, 106:21-27.
5. A receptors in hippocampal neurons. Mol Pharm 2000, 59:814-824.
6. Bannerman D.M., Rawlins J.N.P., McHugh S.B., Deacon R.M.J., Yee B.K., Bast T., Zhang W.-N., Pothuizen H.H.J., Feldon J. Regional dissociations within the hippocampus - memory and anxiety. Neurosci Biobehav Rev 2004, 28:273-283.
7. Barr A.M., Panenka W.J., MacEwan G.W., Thornton A.E., Lang D.J., Honer W.G., Lecomte T. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2009, 31:301-313.
8. Barr J.L., Renner K.J., Forster G.L. Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus. Neuropharmacology 2010, 59:395-405.
9. Basso A.M., Spina M., Rivier J., Vale W., Koob G.F. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology 1999, 145:21-30.
10. A receptors. Neuropharmacology 2002, 43:651-661.
11. A receptor channels from low- to high-efficacy gating patterns. J Neurosci 2003, 23:10934-10943.
12. Bianchi M.T., Haas K.F., Macdonald R.L. Alpha1 and alpha6 subunits specify distinct desensitization, deactivation and neurosteroid modulation of GABA(A) receptors containing the delta subunit. Neuropharm 2002, 43:492-502.
13. A receptor function induced by ethanol withdrawal. J Neurochem 2007, 102:657-666.
14. Bitran D., Dugan M., Renda P., Ellis R., Foley M. Anxiolytic effects of the neuroactive steroid pregnanolone (3α-OH-5β-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res 1999, 850:217-224.
15. Brack K.E., Lovick T.A. Neuronal excitability in the periaqueductal grey matter during the estrous cycle in female Wistar rats. Neuroscience 2007, 144:325-335.
16. Braun A.A., et al. Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regions. Neuroscience 2011, 184:164-171.
17. A receptors. Br J Pharmacol 2002, 136:965-974.
18. Cadet J.L., Krasnova I.N. Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 2009, 88:101-119.
19. Caine S.B., Geyer M.A., Swerdlow N.R. Hippocampal modulation of acoustic startle and pre-pulse inhibition in the rat. Pharmacol Biochem Behav 1992, 43:1201-1208.
20. Carelli R.M. The nucleus accumbens and reward: neurophysiological investigations in behaving animals. Behav Cogn Neurosci Rev 2002, 1:281-296.
21. Charlet A., Lasbennes F., Darbon P., Poisbeau P. Fast non-genomic effects of progesterone-derived neurosteroids on nociceptive thresholds and pain symptoms. Pain 2008, 139:603-609.
22. Chen J., Mitcheson J.S., Lin M., Sanguinetti M.C. Functional roles of charged residues in the putative voltage sensor of the HCN2 pacemaker channel. J Biol Chem 2000, 275:36465-36471.
23. Chiang P.H., Wu P.Y., Kuo T.W., Liu Y.C., Chan C.F., Chien T.C., Cheng J.K., Huang Y.Y., Chiu C.D., Lien C.C. GABA Is Depolarizing in Hippocampal Dentate Granule Cells of the Adolescent and Adult Rats. J Neurosci 2012, 32:62-67.
24. Compagnone N.A., Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 2000, 21:1-56.
25. Concas A., Mostallino M.C., Porcu P., Follesa P., Barbaccia M.L., Trabucchi M., Purdy R.H., Grisenti P., Biggio G. Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci 1998, 95:13284-13289.
26. Costa E., Guidotti A. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci 1991, 49:325-344.
27. Covington H.E., Miczek K.A. Intense cocaine self-administration after episodic social defeat stress, but not after aggressive behavior: dissociation from corticosterone activation. Psychopharmacology 2005, 183:331-340.
28. Cretzmeyer M., Sarrazin M.V., Huber D.L., Block R.I., Hall J.A. Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat 2003, 24:267-277.
29. Curzon P., Zhang M., Radek R.J., Fox G.B. The behavioral assessment of sensorimotor processes in the mouse: acoustic startle, sensory gating, locomotor activity, rotarod, and beam walking. Methods of behavior analysis in neuroscience 2009, 20-31. CRC Press, Boca Raton. second ed. J.J. Buccafusco (Ed.).
30. Davies C.H., Pozza M.F., Collingridge G.L. CGP 55845A: a potent antagonist of GABAB receptors in the CA1 region of rat hippocampus. Neuropharmacology 1993, 32:1071-1073.
31. A receptors. Proc Natl Acad Sci USA 2010, 107:2289-2294.
32. Droogleever Fortuyn H.A., van Broekhoven F., Span P.N., Backstrom T., Zitman F.G., Verkes R.J. Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptors density. Psychoneuroendocrinology 2004, 29:1341-1344.
33. Dobrunz L.E., Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 1997, 18:995-1008.
34. Fadalti M., Petraglia F., Luisi S., Bernardi F., Casarosa E., Ferrari E., Luisi M., Saggese G., Genazzani A.R., Bernasconi S. Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development. Pediatr Res 1999, 46:323-327.
35. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007, 47:681-698.
36. Fowler J.S., et al. Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine. NeuroImage 2008, 423:756-763.
37. Fujiwara-Tsukamoto Y., Isomura Y., Imanishi M., Fukai T., Takada M. Distinct types of ionic modulation of GABA actions in pyramidal cells and interneurons during electrical induction of hippocampal seizure-like network activity. Eur J Neurosci 2007, 25:2713-2725.
38. Galante M., Marty A. Presynaptic ryanodine-sensitive calcium stores contribute to evoked neurotransmitter release at the basket cell-Purkinje cell synapse. J Neurosci 2003, 23:11229-11234.
39. Girdler S.S., Lindgren M., Porcu P., Rubinow D.R., Johnson J.L., Morrow A.L. A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 2012, 37:543-553.
40. Girdler S.S., Straneva P.A., Light K.C., Pedersen C.A., Morrow A.L. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 2001, 49:788-797.
41. Glykys J., Peng Z., Chandra D., Homanics G.E., Houser C.R., Mody I. A new naturally occurring GABA-A receptor subunit partnership with high sensitivity to ethanol. Nat Neurosci 2007, 10:40-48.
42. Gonsalves S.F., Gallager D.W. Persistent reversal of tolerance to anticonvulsant effects and GABAergic subsensitivity by a single exposure to benzodiazepine antagonist during chronic benzodiazepine administration. J Pharmacol Exp Ther 1988, 244:79-83.
43. Grace C.E., Schaefer T.L., Herring N.R., Graham D.L., Skelton M.R., Gudelsky G.A., Williams M.T., Vorhees C.V. Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol 2010, 32:346-355.
44. Grobin A.C., VanDoren M.J., Porrino L.J., Morrow A.L. Cortical 3α-OH-5α-pregnan-20-one levels after acute administration of delta 9-tetracannabinol, cocaine and morphine. Psychopharmacology 2005, 179:544-550.
45. A receptor in the amygdala after progesterone withdrawal. Eur J Neurosci 2003, 17:1-8.
46. Havlikova H., Hill M., Kancheva L., Vrbikova J., Pouzar V., Cerny I., Kancheva R., Starka L. Serum profiles of free and conjugated neuroactive pregnanolone isomers in nonpregnant women of fertile age. J Clin Endocrinol Metab 2006, 91:3092-3099.
47. Hori N., Kadota M.T., Watanabe M., Ito Y., Akaike N., Carpenter D.O. Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons. Cell Mol Neurobiol 2010, 130:849-856.
48. Houston C.M., Bright D.P., Sivilotti L.G., Beato M., Smart T.G. Intracellular chloride ions regulate the time course of GABA-mediated inhibitory synaptic transmission. J Neurosci 2009, 29:10416-10423.
49. Hsu F.-C., Waldeck R., Faber D.S., Smith S.S. Neurosteroid effects on GABAergic synaptic plasticity in hippocampus. J Neurophysiol 2003, 89:1929-1940.
50. - accumulation responsible for depolarizing GABAergic responses in mature hippocampal neurons. J Neurophysiol 2003, 90:2752-2756.
51. Ison J.R., Allen P.D., O'Neill W.E. Age-related hearing loss in C58BL/6J mice has both frequency-specific and non-frequency-specific components that produce a hyperacusis-like exaggeration of the acoustic startle reflex. J Assoc Res Otolaryngol 2007, 8:539-550.
52. Janssen M.J., Ade K.K., Fu Z., Vicini S. Dopamine modulation of GABA tonic conductance in striatal output neurons. J Neurosci 2009, 29:5116-5126.
53. - accumulation and depletion in cultured rat midbrain neurons. J Neurosci 1999, 19:4695-4704.
54. A receptor δ subunit is modulated by brain-derived neurotrophic factor. Neuroscience 2009, 164:507-519.
55. Kahle K.T., Staley K.J., Nahed B.V., Gamba G., Hebert S.C., Lifton R.P., Mount D.B. Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol 2008, 4:490-503.
56. Kamei J., Ohsawa M. Effects of diabetes on methamphetamine-induced place preference in mice. Eur J Pharmacol 1996, 318:251-256.
57. Kitanaka J., Kitanaka N., Takemura M. Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review. Neurochem Res 2008, 33:204-219.
58. Kitanaka N., Kitanaka J., Tatsuta T., Tanaka K., Watabe K., Nishiyama N., Morita Y., Takemura M. Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-5-hydroxyphylglycol and induces the expression of anxiety-related behavior in mice. Neurochem Res 2010, 35:749-760.
59. Kiyatkin E.A., Sharma H.S. Expression of heat shock protein (HSP 72kDa) during acute methamphetamine intoxication depends on brain hyperthermia: neurotoxicity or neuroprotection?. J Neural Transm 2011, 118:47-60.
60. A receptors α4β2γ2 and α6β2γ2. Mol Pharmacol 1996, 50:1253-1261.
61. Koob G.F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry Suppl 2009, 1:S32-S41.
62. Kumar S., Sieghart W., Morrow A.L. Association of protein kinase C with GABA(A) receptors containing alpha1 and alpha4 subunits in the cerebral cortex: Selective effects of chronic ethanol consumption. J Neuro Chem 2002, 82:110-117.
63. A receptors by high efficacy states. Brain Res 2012, 1463:1-20.
64. Ladenheim B., Krasnova I.N., Deng X., Oyler J.M., Polettini A., Moran T.H., Huestis M.A., Cadet J.L. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol Pharmacol 2000, 58:1247-1256.
65. A receptor-mediated dendritic inhibition in area CA1 of the rat hippocampus. J Neurophysiol 1991, 66:1538-1548.
66. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004, 61:73-84.
67. Luisi S., Petraglia F., Benedetto C., Nappi R.E., Bernardi F., Fadalti M., Reis F.M., Luisi M., Genazzani A.R. Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 2000, 85:2429-2433.
68. A receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 2005, 8:797-804.
69. Mancino M.J., Gentry B.W., Feldman Z., Mendelson J., Oliveto A. Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study. Am J Drug Alcohol Abuse 2011, 37:131-136.
70. Mason M.J., Simpson A.K., Mahaut-Smith M.P., Robinson H.P. The interpretation of current-clamp recordings in the cell-attached patch-clamp configuration. Biophys J 2005, 88:739-750.
71. A receptors. J Neurophysiol 2011, 106:2057-2064.
72. A receptors are involved in mediating stimulant effects of cocaine. Pharmacol Biochem Behav 2008, 90:9-18.
73. A receptor-mediated tonic inhibition in dentate granule cells after traumatic brain injury. Neurobiol Dis 2010, 38:464-475.
74. Mukai H., Higashi T., Nagura Y., Shimada K. Studies on neurosteroids XXV. Influence of 5α-reductase inhibitor, finasteride, on rat brain neurosteroid levels and metabolism. Biol Pharm Bull 2008, 31:1646-1650.
75. Nie H., Rewal M., Gill T.M., Ron D., Janak P.H. Extrasynaptic delta-containing GABAA receptors in the nucleus accumbens dorsomedial shell contribute to alcohol intake. Proc Natl Acad Sci U S A 2011, 108:4459-4464.
76. Numachi Y., Yoshida S., Toda S., Matsuoka H., Sato M. Two inbred strains of rats, Fischer 344 and Lewis, showed differential behavior and brain expression of corticosterone receptor mRNA induced by methamphetamine. Ann N Y Acad Sci 2000, 914:33-45.
77. Olsen R.W., Snowman A. Chloride-dependent enhancment by barbiturates of gamma-aminobutyric acid receptor binding. J Neuroscience 1982, 2:1812-1823.
78. A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 2009, 56:141-148.
79. Palumbo M.A., Salvestroni C., Gallo R., Guo A.L., Gennazini A.D., Artini P.G., Petraglia F., Gennazani A.R. Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle. J Endocrinol Invest 1995, 18:853-856.
80. A receptor expression in cultured mouse cerebellar granule neurones. J Neurochem 2008, 104:173-186.
81. Payne J.A. Functional characterization of the neuronal-specific K-Cl cotransporter: implications for [K+]o regulation. Am J Physiol 1997, 273:C1516-C1525.
82. A receptor changes in δ subunit-deficient mice: altered expression of α4 and γ2 subunits in the forebrain. J Comp Neurol 2002, 446:179-197.
83. Perkins K.L. Cell-attached voltage-clamp and current-clamp recording and stimulation techniques in brain slices. J Neurosci Methods 2006, 154:1-18.
84. Pignataro L., Miller A.N., Ma L., Midha S., Protiva P., Herrera D.G., Harrison N.L. Alcohol regulates gene expression in neurons via activation of heat shock factor 1. J Neurosci 2007, 27:12957-12966.
85. A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
86. Pometlova M., Nohejlova-Deykun K., Slamberova R. Anxiogenic effect of low-dose methamphetamine in the test of elevated plus-maze. Prague Med Rep 2012, 113:223-230.
87. Porcu P., O'Buckley T.K., Alward S.E., Song S.C., Grant K.A., de Wit H., Leslie Morrow A. Differential effects of ethanol on serum GABAergic 3α,5α/3α,5β neuroactive steroids in mice, rats, cynomolgus monkeys, and humans. Alcohol Clin Exp Res 2010, 34:432-442.
88. Porcu P., O'Buckley T.K., Alward S.E., Marx C.E., Shampine L.J., Girdler S.S., Morrow A.L. Simultaneous quantification of GABAergic 3α,5α/3α,5β neuroactive steroids in human and rat serum. Steroids 2009, 74:463-473.
89. Purdy R.H., Morrow A.L., Moore P.H., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat. PNAS 1991, 88:4553-4557.
90. Quinones-Jenab V., Minerly A.C., Niyomchia T., Akahvan A., Jenab S., Frye C. Progesterone and allopregnanolone are induced by cocaine in serum and brain tissues of male and female rats. Pharmacol Biochem Behav 2008, 89:292-297.
91. Reilly W., Koirala B., Devaud L.L. Sex differences in acoustic startle responses and seizure thresholds between ethanol-withdrawn male and female rats. Alcohol Alcohol 2009, 44:561-566.
92. Rewal M., Donahue R., Gill T.M., Nie H., Ron D., Janak P.H. Alpha4 subunit-containing GABAA receptors in the accumbens shell contribute to the reinforcing effects of alcohol. Addict Biol 2012, 17:309-321.
93. Rhodes M.E., Frye C.A. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cogn Affect Behav Neurosci 2001, 1:287-296.
94. Rhodes M.E., McCormick C.M., Frye C.A. 3α,5α-THP mediates progestins' effects to protect against adrenalectomy-induced cell death in the dentate gyrus of female and male rats. Pharmacol Biochem Behav 2004, 78:505-512.
95. Riviere G.J., Byrnes K.A., Gentry W.B., Owens S.M. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 1999, 291:1220-1226.
96. Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., Cottone P., Madamba S.G., Stouffer D.G., Zorrilla E.P., Koob G.F., Siggins G.R., Parsons L.H. Corticotropin releasing factor-induced amygdala γ-aminobutyric acid release plays a key role in alcohol dependence. Biol Psychiatry 2010, 67:831-839.
97. Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T., Raber J. ApoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiol Aging 2005, 26:637-643.
98. A receptor regulation in culture: Altered allosteric interactions following prololonged exposure to benzodiazepines, barbiturates, and methylxanthines. Mol Pharmacol 1990, 37:710-719.
99. A receptor subtypes. Nature 1999, 401:796-800.
100. Sabaliauskas N., Shen H., Homanics G.E., Smith S.S., Aoki C. Knockout of the γ-aminobutyric acid receptor subunit α4 reduces functional δ-containing extrasynaptic receptors in hippocampal pyramidal cells at the onset of puberty. Brain Res 2012, 1450:11-23.
101. Salo R., Flower K., Kielstein A., Leamon M.H., Nordahl T.E., Galloway G.P. Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res 2011, 186:356-361.
102. A currents. Neuroscience 2010, 167:644-655.
103. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res 1995, 675:89-97.
104. A receptors triggers anxiety at puberty. Nat Neurosci 2007, 10:469-477.
105. A receptors in shaping learning deficits at puberty in mice. Science 2010, 327:1515-1518.
106. A receptors in shaping learning deficits at puberty in mice. Science 2010, 327:1515-1518.
107. Shepard J.D., Bossert J.M., Liu S.Y., Shaham Y. The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry 2004, 55:1082-1089.
108. Shoptaw S.J., Kao U., Heinzerling K., Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2009, CD003021.
109. Smith R.J., Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 2008, 213:43-61.
110. Smith S.S., Ruderman Y., Frye C.A., Homanics G.E., Yuan M. Steroid withdrawal in the mouse results in anxiogenic effects of 3α,5β-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 2006, 186:323-333.
111. A receptor-mediated postsynaptic conductance. J Neurophysiol 1992, 68:197-212.
112. - transport. J Physiol 1999, 519:693-712.
113. A receptors. Proc Natl Acad Sci 2003, 100:14439-14444.
114. A conductances in hippocampal neurons. J Neurosci 2002, 22:RC223.
115. Tan K.R., Brown M., Labouebe G., Yvon C., Creton C., Fritschy J.M., Rudolph U., Luscher C. Neural bases for addictive properties of benzodiazepines. Nature 2010, 463:769-774.
116. Toufexis D.J., Davis C., Hammond A., Davis M. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci 2004, 24:10280-10287.
117. Wafford K.A., Thompson S.A., Sikela J., Wilcox A.S., Whiting P.J. Functional characterization of human GABA receptors containing the α4 subunit. Mol Pharmacol 1996, 50:670-678.
118. A receptors are reversed by the behavioral alcohol antagonist Ro15-4513. Proc Natl Acad Sci 2006, 103:8540-8545.
119. Waselus M., Valentino R.J., Van Bockstaele E.J. Ultrastructural evidence for a role of γ-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system. J Comp Neurol 2005, 482:155-165.
120. A receptors and their activation by GABA spillover in the mouse dentate gyrus. J Neurosci 2003, 23:10650-10661.
121. A receptors. Br J Anaesth 2004, 92:704-711.
122. Wieland H.A., Luddens H., Seeburg P.H. A single histidine in GABA-A receptors is essential for benzodiazepine agonist binding. J Biol Chem 1992, 267:1426-1429.
123. Willott J.F., Turner J.G., Sundin V.S. Effects of exposure to an augmented acoustic environment on auditory function in mice: roles of hearing loss and age during treatment. Hear Res 2000, 142:79-88.
124. Yamamoto H., Kitamura N., Lin X.H., Ikeuchi Y., Hashimoto T., Shirakawa O., Maeda K. Differential changes in glutamatergic transmission via N-methyl-d-aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine. Int J Neuropsychopharmacol 1999, 2:155-163.
125. A receptor subunit mRNA expression, translation product assembly and channel function in neuronal cultures. J Pharmacol Exp Ther 1996, 277:525-533.
126. Zhou X., Smith S.S. Expression levels of the alpha4 subunit of the GABA(A) receptor in differentiated neuroblastoma cells are correlated with GABA-gated current. Neuropharm 2009, 56:1041-1053.
127. Zhu J.P., Xu W., Angulo N., Angulo J.A. Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration. Neurotoxicology 2006, 27:131-136.
128. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology 2001, 158:374-381.